{"database": "lobbying", "table": "lobbying_activities", "rows": [[2683259, "32d78c5a-181e-421c-9d37-55d40901fefb", "Q3", "GOVERNMENT COUNSEL, LLC", 401105070, "APOTEX CORPORATION", 2021, "third_quarter", "MAN", "Americas Supply Chains Executive Order 14017 of Feb 24, 2021 [86 Fed. Reg. 11849 (March 1, 2021)]. Policies relating to strengthening domestic manufacturing of active pharmaceutical ingredients and finished dosages.", "Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),SENATE", 50000, null, 0, 0, "2021-10-17T11:41:07.670000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2683259"], "units": {}, "query_ms": 5.734336096793413, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}